Expected Paradigm Shift in Brain Metastases Therapy—Immune Checkpoint Inhibitors
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Expected Paradigm Shift in Brain Metastases Therapy—Immune Checkpoint Inhibitors
Authors
Keywords
Brain metastasis, Ipilimumab, Immune checkpoint inhibitors, Pembrolizumab
Journal
MOLECULAR NEUROBIOLOGY
Volume 55, Issue 8, Pages 7072-7078
Publisher
Springer Nature
Online
2018-01-30
DOI
10.1007/s12035-018-0905-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Trends and advances in tumor immunology and lung cancer immunotherapy
- (2016) Mohanad Aldarouish et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Activity and safety of ceritinib in patients with ALK -rearranged non-small-cell lung cancer (ASCEND-1): updated results from the multicentre, open-label, phase 1 trial
- (2016) Dong-Wan Kim et al. LANCET ONCOLOGY
- Updates in the management of brain metastases
- (2016) Nils D. Arvold et al. NEURO-ONCOLOGY
- The evolution of checkpoint blockade as a cancer therapy: what's here, what's next?
- (2015) Daniel Sanghoon Shin et al. CURRENT OPINION IN IMMUNOLOGY
- 3083 AZD9291 activity in patients with EGFR-mutant advanced non-small cell lung cancer (NSCLC) and brain metastases: Data from Phase II studies
- (2015) M.J. Ahn et al. EUROPEAN JOURNAL OF CANCER
- Swinging for the Fences: Long-Term Survival With Ipilimumab in Metastatic Melanoma
- (2015) Geoffrey T. Gibney et al. JOURNAL OF CLINICAL ONCOLOGY
- ORAL SESSIONS
- (2015) Journal of Thoracic Oncology
- Targeted Therapy for Brain Metastases in EGFR-Mutated and ALK-Rearranged Non-Small-Cell Lung Cancer
- (2015) Christina S. Baik et al. Journal of Thoracic Oncology
- T-cell exhaustion in the tumor microenvironment
- (2015) Y Jiang et al. Cell Death & Disease
- Ipilmumab and cranial radiation in metastatic melanoma patients: a case series and review
- (2015) Jonathan D. Schoenfeld et al. Journal for ImmunoTherapy of Cancer
- Three-year follow-up of advanced melanoma patients who received ipilimumab plus fotemustine in the Italian Network for Tumor Biotherapy (NIBIT)-M1 phase II study
- (2014) A. M. Di Giacomo et al. ANNALS OF ONCOLOGY
- Acquired Resistance to Fractionated Radiotherapy Can Be Overcome by Concurrent PD-L1 Blockade
- (2014) S. J. Dovedi et al. CANCER RESEARCH
- Irradiation and anti–PD-L1 treatment synergistically promote antitumor immunity in mice
- (2014) Liufu Deng et al. JOURNAL OF CLINICAL INVESTIGATION
- Safety and activity of alectinib against systemic disease and brain metastases in patients with crizotinib-resistant ALK-rearranged non-small-cell lung cancer (AF-002JG): results from the dose-finding portion of a phase 1/2 study
- (2014) Shirish M Gadgeel et al. LANCET ONCOLOGY
- Patterns of response and progression in patients withBRAF-mutant melanoma metastatic to the brain who were treated with dabrafenib
- (2013) Mary W. F . Azer et al. CANCER
- Checkpoint blocking antibodies in cancer immunotherapy
- (2013) Chrisann Kyi et al. FEBS LETTERS
- Ipilimumab and radiation therapy for melanoma brain metastases
- (2013) Ann W. Silk et al. Cancer Medicine
- Characterization of the inflammatory response to solid cancer metastases in the human brain
- (2012) Anna Sophie Berghoff et al. CLINICAL & EXPERIMENTAL METASTASIS
- Radiosurgery for melanoma brain metastases in the ipilimumab era and the possibility of longer survival
- (2012) Jonathan P. S. Knisely et al. JOURNAL OF NEUROSURGERY
- Ipilimumab and fotemustine in patients with advanced melanoma (NIBIT-M1): an open-label, single-arm phase 2 trial
- (2012) Anna Maria Di Giacomo et al. LANCET ONCOLOGY
- Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial
- (2012) Kim Margolin et al. LANCET ONCOLOGY
- Increase of regulatory T cells in metastatic stage and CTLA-4 over expression in lymphocytes of patients with non-small cell lung cancer (NSCLC)
- (2012) Nasrollah Erfani et al. LUNG CANCER
- Ipilimumab in a Phase II trial of melanoma patients with brain metastases
- (2012) Kim Margolin OncoImmunology
- An immune-active tumor microenvironment favors clinical response to ipilimumab
- (2011) Rui-Ru Ji et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Host type I IFN signals are required for antitumor CD8+T cell responses through CD8α+dendritic cells
- (2011) Mercedes B. Fuertes et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Type I interferon is selectively required by dendritic cells for immune rejection of tumors
- (2011) Mark S. Diamond et al. JOURNAL OF EXPERIMENTAL MEDICINE
- A Perspective on Cancer Cell Metastasis
- (2011) C. L. Chaffer et al. SCIENCE
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- Heterogeneous Blood-Tumor Barrier Permeability Determines Drug Efficacy in Experimental Brain Metastases of Breast Cancer
- (2010) P. R. Lockman et al. CLINICAL CANCER RESEARCH
- The origins of cancer robustness and evolvability
- (2010) Tianhai Tian et al. Integrative Biology
- Outcome predictors of Gamma Knife surgery for melanoma brain metastases
- (2010) Donald N. Liew et al. JOURNAL OF NEUROSURGERY
- Cavity-directed radiosurgery as adjuvant therapy after resection of a brain metastasis
- (2010) Courtney A. Jensen et al. JOURNAL OF NEUROSURGERY
- Neurological complications of systemic cancer
- (2010) Mustafa Khasraw et al. LANCET NEUROLOGY
- Complete regression of a previously untreated melanoma brain metastasis with ipilimumab
- (2010) Noël E.C. Schartz et al. MELANOMA RESEARCH
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Prevalence of FOXP3+ Regulatory T-Cells in Peripheral Blood of Patients with NSCLC
- (2009) Liu Li et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
- CTLA-4 blockade with ipilimumab induces significant clinical benefit in a female with melanoma metastases to the CNS
- (2008) F Stephen Hodi et al. Nature clinical practice. Oncology
- Stereotactic Radiosurgery of the Postoperative Resection Cavity for Brain Metastases
- (2007) Scott G. Soltys et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search